Â¥
12.35
May 17
New Key Statistics Module, Z-Score and F-Score
SZSE:300630 Key Ratios
Market Cap ¥ M | 5,579.42 |
Enterprise Value ¥ M | 7,762.51 |
P/E(ttm) | 17.64 |
PE Ratio without NRI | 16.67 |
Forward PE Ratio | -- |
Price/Book | 1.76 |
Price/Sales | 3.44 |
Price/Free Cash Flow | -- |
Price/Owner Earnings | -- |
Payout Ratio % | 0.11 |
Revenue (TTM) ¥ M | 1,787.00 |
EPS (TTM) ¥ | 0.70 |
Beneish M-Score | -2.33 |
10-y EBITDA Growth Rate % | 34.00 |
5-y EBITDA Growth Rate % | 32.30 |
y-y EBITDA Growth Rate % | -44.20 |
EV-to-EBIT | 20.19 |
EV-to-EBITDA | 20.19 |
PEG | 0.52 |
Shares Outstanding M | 451.78 |
Net Margin (%) | 20.66 |
Operating Margin % | 22.17 |
Pre-tax Margin (%) | 21.20 |
Quick Ratio | 1.64 |
Current Ratio | 1.93 |
ROA % (ttm) | 6.01 |
ROE % (ttm) | 12.51 |
ROIC % (ttm) | 7.49 |
Dividend Yield % | 0.64 |
Altman Z-Score | 2.02 |
SZSE:300630 Number of Guru Trades
SZSE:300630 Volume of Guru Trades
Gurus Latest Trades with SZSE:300630
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
SZSE:300630 is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Hainan Poly Pharm Co Ltd Insider Transactions
No Available Data